
1. infect immun. 2013 apr;81(4):1031-9. doi: 10.1128/iai.00978-12. epub 2013 jan 14.

antibodies escherichia coli-expressed c-terminal domains plasmodium
falciparum variant surface antigen 2-chondroitin sulfate (var2csa) inhibit
binding csa-adherent parasites placental tissue.

saveria t(1), oleinikov av, wiliamson k, chaturvedi r, lograsso j, keitany gj,
fried m, duffy p.

author information: 
(1)seattle biomedical research institute, seattle, washington, usa.

placental malaria (pm) characterized infected erythrocytes (ies) that
selectively bind chondroitin sulfate (csa) sequester placental
tissue. variant surface antigen 2-csa (var2csa), plasmodium falciparum
erythrocyte membrane protein 1 (pfemp1) protein family member, expressed on
the surface placental ies mediates adherence csa surface of
syncytiotrophoblasts. transmembrane protein contains 6 duffy binding-like
(dbl) domains might contribute specific adhesive properties ies. 
here, use laboratory isolate 3d7 var2csa dbl domains expressed escherichia 
coli generate antibodies specific protein. flow cytometry results
showed antibodies generated dbl4ε, dbl5ε, dbl6ε, tandem double
domains dbl4-dbl5 dbl5-dbl6 bind placental parasite isolates to
lab strains selected csa binding bind children's parasites.
antisera dbl4ε dbl5ε inhibit maternal ie binding placental tissue in
a manner comparable plasma collected multigravid women. these
antibodies also inhibit binding csa several field isolates derived from
pregnant women, antibodies double domains enhance functional 
immune response. data support dbl4ε dbl5ε vaccine candidates for
pregnancy malaria demonstrate e. coli feasible tool the
large-scale manufacture vaccine based var2csa domains.

doi: 10.1128/iai.00978-12 
pmcid: pmc3639618
pmid: 23319559  [indexed medline]

